medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Número 4

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (4)


Materiales de relleno en dermatología

Cheng FI, Moreno GJL

Idioma: Español
Referencias bibliográficas: 70
Paginas: 275-285
Archivo PDF: 153.73 Kb.


RESUMEN

Un material de relleno es una sustancia que se inyecta en el cuerpo. Se pueden clasificar según la profundidad de la implantación (dérmicos, subdérmicos y periósticos); la duración (temporales, semipermanentes y permanentes); su naturaleza (naturales, semisintéticos, sintéticos); su composición; y su comportamiento- estímulo (rellenos o bioestimulantes).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hoefflin SM. “The youthful face: tight is not right, repositioning is right”. Plas Reconstr surg 1998; 101: 1417.

  2. Hasson AN. “Rellenos e inyectables en dermatología”. Rev chilena dermatol 2008; 24: 195-196.

  3. Neuber F. “Fettransplation”. Cuit Krongr VerhGesl Chir 1893; 22: 66.

  4. Gersvny R. “Veber eine subcutgane prosthese”. Zstschr Heil Kunde 1992; 26: 1-8.

  5. Vedamurthy M. “Soft tissue augmentation-use of hyaluronic acid as dermal filler”. J Indian Dermatol Venereol Leprol 2004; 70: 383-387.

  6. Wollina U, Goldman A, Berger U, Abdel- Naser MB. “Esthetic and cosmetic Dermatology”. Dermatol Ther 2008; 21: 118-130.

  7. Vedamurthy M. “Standard guidelines for the use of dermal fillers”. J Indian Dermatol Venereol Leprol 2008; 74(Suppl1): s23-s27.

  8. Sturm LP, Cooter RD, Mutimer KL Graham JC, Maddern GJ. “A systemic review of dermal fillers for HIV-Associated facial Lipoatrophy”. AIDS Patient Care STDS 2009; 23: 699-714

  9. Pinski KS. “Soft tissue augmentation for the new millennium”. Dermatol Ther 2000; 13: 192-197.

  10. Drake L, Dinehart SM, Farmer ER, et al. “Guidelines of care for soft tissue augmentation”. Am Acad Dermatol 1996: 36: 695-607.

  11. Baumann L, Kaufman J, Saghari Sogol. “Collagen Fillers”. Dermatol Ther 2006; 19: 134-140.

  12. Castrow FF, Krull EA. “Injectable collagen implant-update”. J Am Acad Dermatol 1998; 9: 889-893.

  13. Siegel RJ, McCoy JP, Schade W, Swanson NA. “Intradermal implantion of bovine collagen. Humoral responses associated with clinical reactions”. Arc Dermatol 1984; 120: 183-187.

  14. Bauman L. “CosmoDerm/CosoPlast (human bioengineered collagen) for the aging face”. Facial Plast Surg 2004; 20: 125-128.

  15. Perret S, Eble JA, Siljander PR, et al. “Prolyhydroxylation of collagen type I is required for efficient binding to integrin alpha 1 beta and platelet glycoprotein VI but not to alpha 2 beta”. J Biol Chem 2003; 278: 29873- 29879.

  16. Okada S, Hagan JB, Kato M, et al. “Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils”. J Immunol 1998; 160: 4010-4017.

  17. Roo-Rodríguez E. “La elección del material de relleno”. Piel 2007; 22: 481-482.

  18. Matarasso SL. “Injectable collagens: lost but not forgotten—a review” of products, indications, and injection techniques. Plast Reconstr Rurg 2007; 120 (Suppl6): s17-s26.

  19. Glaich A, Cohen J, Goldberg L. “Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers”. Dermatol Surg 2006; 32: 276-281.

  20. Conejo-Mir J, Moreno JC, Camacho FM. Manual de dermatología. 1ª Ed. España, Biblioteca Aula Médica, 2010: 1363-1379.

  21. Tezel A, Fredrickson GH. “The science of hyaluronic acid dermal fillers”. J Cosmet Laser Ther 2008; 10: 35-42.

  22. Sharma P, Sharma S. “Comparative study of new dermal filler Uma Jeunesse and Juvéderm”. J Cosmet Dermatol 2011; 10: 118-125.

  23. Gold M. “The science and art of hyaluronic acid dermal filler use in esthetic applications”. J Cosmet Dermatol 2009; 8: 301-308.

  24. Born T. “Hyaluronic acids”. Clin Plast Surg 2006; 33: 525-538.

  25. Lupo Mp. “Hyaluronic acid fillers in facial rejuvenation”. Semin Cutan Med Surg 2006; 25: 122-126.

  26. Kablik J, Monheit GD, Yu L, Chang G. “Comparative Physical properties of Hyaluronic Acid Dermal fillers”. Dermato Surg 2009; 35: 302-312.

  27. Andre P. “New trends in face rejuvenation by hyaluronic acid injections”. J Cosmet Dermatol 2008; 7: 251-258.

  28. Whal G. “European evaluation of a new hyaluronic acid filler incorporating lidocaine”. J Cosmet Dermatol 2008; 7: 298-303.

  29. Raspaldo H. “Volumizing effect of a new hyaluronic acid sub-dermal facial filler: A retrospective analysis base don 102 cases”. J Cosmet Laser Ther 2008; 10: 134-142.

  30. Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, et al. “ stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin”. Arch Dermatol 2007; 143: 155-163.

  31. Baumann. « « Dermal Fillers. J Cosmet Dermatol 2004; 4: 249-250.

  32. Grimes P, Thomas JA, Murphy D. “Safety and effectivess of hyaluronic acid fillers in skin of color”. J Cosmet Dermatol 2009; 8: 162-168.

  33. Vleggaar D, Bauer U. “Facial enhancement and the European experience whit Sculptra (poly-L-lactic acid)”. J Drugs Dermatol 2004; 1: 542- 547.

  34. Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS. “Applications of biodegradable lactides and glycolides in podiatry”. Clin Podiatri Med Surg 1995; 1: 475-495.

  35. Humble G, Mest D. “Soft tissue augmentation using sculptra”. Facial Plast Surg 2004; 20: 157-163.

  36. Rotunda AM, Narins RS. “Poly-L-lactic acid: a new dimension in soft tissue augmentation”. Dermatol Ther 2006; 19: 151-158.

  37. Lowe N, Maxwell A, Rickie P. “Adverse reaction to dermal fillers: review”. Dermatol Surg 2005; 31: 1626-1633.

  38. Narins RS, Baumman L, Brandt FS, Fagien S, et al. « A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus humanbases collagen implant in the treatment of nasolabial fold wrinkles”. J Am Acad Dermatol 2010; 62: 448-462.

  39. Berlin A. Cohen JL, Goldberg DJ. “Calcium hydroxylapatitae for facial rejuvenation”. Semin Cutan Med Surg 2006; 25; 132-137.

  40. Alam M, Havey J, Pace N, Pongprutthipan M, et al. “Large-particle calcium hidroxypatite injection for correction of facial wrinkles and depressions”. J Am Acad Dermatol 2011; 65: 92-96.

  41. Alam M, Yoo SS. “Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions”. J Am Acad Dermatol 2007: 56: 285-289.

  42. Marmur E, Green L, Busso M. “Controlled, Randomized Study of Pain Levels in Subjects Treated with Calcium Hydroxylapatite premixed with lidocaine for correction of nasolabial folds”. Dermatolocis Surgery 2010; 36: 309-315.

  43. Fox LP, Geyer AS, Husain S, Della-Latta P, et al. “Mycobacterium abscessus cellulitis and multifocal abscesses of the breast in a transexual from illicit intramammary injections of silicone”. J Am Acad Dermatol 2004; 50: 450-454.

  44. Houpt K. “Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty”. J Am Acad Dermatol 1994; 31: 626-642.

  45. Hevia O. “”Liquid injectable silicone (polydimethylsiloxane): four years of clinical experience. J Am Acad Dermatol. 2007; 56 SUPPL 2: AB1.

  46. Arin MJ, Bäte J, Krieg T, Hunzelmman N. “Silicone granuloma of the face treated with minocycline”. J Am Acad Dermatol 2005; 52: (Suppl1): s53-s56.

  47. Orentreich D, Leone AS. “A case of HIV- associated facial lipoatrophy treated with 1000-cs liquid injectable silicone”. Dermatol Surg 2004; 30: 548-551.

  48. Pacini S, Ruggiero M, Morucci G, Cammarota N, Protopapa C, Gulisano M. “Bio-alcamid: a novelty for reconstructive and cosmetic surgery”. Ital J Anat Embryol 2002; 107(3): 209-214.

  49. Loutfy MR, Raboud JM, Antoniou T, Kovacs C, Shen S, Halpenny R, et al. “Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients”. AIDS 2007; 21(9): 1147-1155.

  50. Karim RB, de Lint CA, van Galen SR, van Rozelaar L, Nieuwkerk PT, Askarizadeh E, et al. “Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients”. Aesthetic Plast Surg 2008; 32(6): 873-878.

  51. Ross AH, Malhotra R. “Long-term orbitofacial complications of polyalkylimide 4% (bio-alcamid)”. Ophthal Plast Reconstr Surg 2009; 25(5): 394-397.

  52. Ocampo Candiani J, Sobrevilla Ondarza S, Velázquez Arenas L, Vázquez Martínez OT. “Complication of a polyalkylimide implant in a patient with facial trauma”. Dermatol Surg 2008; 34(9):1280-1282.

  53. Pallua N, Wolter TP. “A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients”. Plast Reconstr Surg 2010; 125(6): 1797-1804.

  54. Ono S, Ogawa R, Hyakusoku H. “Complications after polyacrylamide hydrogel injection for soft-tissue augmentation”. Plast Reconstr Surg 2010; 126(4):1349-1357.

  55. Ogden S, Griffitsh TW. “A review of minimally invasive cosmetic procedures”. Br Journal Dermat 2008; 159: 1036-1050.

  56. Narins RS. “Five years postapproval study of novel polymethylmethacrylate soft tissue filler: Year 1 interim analysis”. J Am Acad Dermatol 2009; 60 SUPPLE1: AB190.

  57. Glashofer M, Lawrance L. “Fat transplantation for treatment of the senescent face”. Dermatol Ther 2006; 19: 169-176.

  58. Berman M. “Rejuvenation of the upper eyelid complex with autologous fat transplantation”. Dermatol Surg 2000; 26: 1113-116.

  59. Guaraldi G, De fazio D, Orlando G, Murri R, et al. “Facial lipohypertrophy in HIV- infected subjects who underwent autologous fat tissue transplantation”. Clin Infect Dis 2005; 40: 13-15.

  60. Roh MR, Jung JY, Chung KY. “Autologous fat transplantation for depressed linear Pulgam S, Poulton T, Mamounas EP. “Long-Term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature”. Breast J 2006; 16: 63-65.

  61. Roh MR, Kim TK, Chung KY. “Treatment of infraorbital dark circles by autologous fat transplantation: a pilot study”. Br J Dermatol 2009; 160: 1022: 10025.

  62. Donofrio LM. “Structural autologous lipoaugmentation: A pan-facial technique”. Dermatol Surg 2000: 26: 1129-1134.

  63. Shiffman MA, Mirrafati S. “Fat transfer techniques: the effect of harvest and transfers methods on adipocyte viability and review of literature”. Dermatol Surg 2001; 27: 819-826.

  64. Kranendonk S, Obagi S. “Autologous fat transfer for periorbital rejuvenation: indications, technique and complications”. Dermatol Surg 2007; 33: 572-578.

  65. Mioshi K, Miyaoka T, Kobayashi Y, et al. “Hypergamma-globulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty”. Ijishimpo 1964; 2122: 9-14.

  66. Lemperle G, Morhenn V, Charrier U. “Human histology and persistence of various injectable filler substances for soft tissue augmentation”. Aesth Plast Surg 2003; 27: 354-366.

  67. Priego RB, Cárdenas RJ, Pérez R, et al. “Enfermedad humana por modelantes. Análisis de sustancias con espectrometría de resonancia magnética”. Cirugía Plástica 2010; 20 (3): 120-123.

  68. Gabriel SE, O’Fallon WM, Kurland LT, et al. “Risk of Connective-Tissue Diseases and Other Disorders after Breast Implantation”. N Engl J Med 1994; 330: 1697-1702.

  69. Lee IM, Cook NR, Shadick NA, Pereira E, Buring JE. “Prospective cohort study of breast implants and the risk of connective-tissue diseases”. Int J Epidemiol 2011; 40(1): 230-238.

  70. Khan I, Shokrollahi K, Bisarya K, Murison MS. “A liposuction technique for extraction of Bio-Alcamid and other permanent fillers”. Aesthet Surg J 2011; 31(3): 344-346.




2020     |     www.medigraphic.com